Fidelity Disruptive Medicine ETF (FMED)
| Assets | $51.08M |
| Expense Ratio | 0.50% |
| PE Ratio | 39.73 |
| Shares Out | 2.12M |
| Dividend (ttm) | $0.00 |
| Dividend Yield | 0.00% |
| Ex-Dividend Date | Jun 21, 2024 |
| Payout Ratio | 0.17% |
| 1-Year Return | -4.07% |
| Volume | 5,542 |
| Open | 23.87 |
| Previous Close | 23.88 |
| Day's Range | 23.73 - 23.88 |
| 52-Week Low | 19.88 |
| 52-Week High | 25.68 |
| Beta | 0.95 |
| Holdings | 65 |
| Inception Date | Apr 16, 2020 |
About FMED
Fund Home PageThe Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is issued by Fidelity.
Top 10 Holdings
38.47% of assets| Name | Symbol | Weight |
|---|---|---|
| Boston Scientific Corporation | BSX | 6.60% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 5.17% |
| UnitedHealth Group Incorporated | UNH | 4.28% |
| Intuitive Surgical, Inc. | ISRG | 3.96% |
| Danaher Corporation | DHR | 3.67% |
| Insulet Corporation | PODD | 3.61% |
| Centene Corporation | CNC | 3.15% |
| Regeneron Pharmaceuticals, Inc. | REGN | 2.76% |
| Eli Lilly and Company | LLY | 2.68% |
| Stryker Corporation | SYK | 2.59% |
News
An Advisor's Guide to Fidelity's Disruptive ETF Suite
Thematic investing continues to garner attention at the midyear point on sustained artificial intelligence interest. For advisors and investors looking to diversify their thematic holdings, the Disrup...
Why traditional active managers are joining the ETF space
Greg Friedman, head of ETF management and strategy at Fidelity Investments, joins 'Halftime Report' to discuss a spike in ETF flows going to active management, Fidelity's decision to convert mutual fu...